Timothy I. Still

Independent Director

Mr. Still has been directly responsible for building the commercial viability at many of his previous companies, 5 of which have been successfully acquired (representing > $1.1 B in proceeds). Tim was most recently the President and CEO of Myoscience, located in Fremont, CA.  Mr. Still was hired to develop a new commercial strategy at the company, and re-direct the technology platform into the pain management / orthopedic marketplace. While leading Myoscience, he raised over $12 M in convertible debt, rebuilt the commercial organization, and successfully negotiated a strategic exit in the Spring of 2019.  Myoscience was acquired by Pacira Pharmaceuticals for a valuation of ~40X trailing revenue - in an industry known for valuation ranges of ~7X. Mr. Still received a B.S. degree (with Honors) in Biological Sciences from the University of California at Davis, and an MBA (Deans Scholar) in Marketing and Entrepreneurship from the University of Southern California.